CSF pT217/T217 increased in AD compared to normal control, FTLD-TDP and FTLD-tau (P < 0.0001) and can differentiate AD from FTLD-tau with an AUC of 0.987 (Supplementary Fig. 3c). The gene discussed is MAPT; the disease is Alzheimer disease.